Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun;1(3):151-9.
doi: 10.1177/2050640613484463.

Lactose malabsorption and intolerance: pathogenesis, diagnosis and treatment

Affiliations

Lactose malabsorption and intolerance: pathogenesis, diagnosis and treatment

Benjamin Misselwitz et al. United European Gastroenterol J. 2013 Jun.

Abstract

Lactose malabsorption is a common condition caused by reduced expression or activity of lactase in the small intestine. In such patients, lactose intolerance is characterized by abdominal symptoms (e.g. nausea, bloating, and pain) after ingestion of dairy products. The genetic basis of lactose malabsorption is established and several tests for this condition are available, including genetic, endoscopic, and H2-breath tests. In contrast, lactose intolerance is less well understood. Recent studies show that the risk of symptoms after lactose ingestion depends on the dose of lactose, lactase expression, intestinal flora, and sensitivity of the gastrointestinal tract. Lactose intolerance has recently been defined as symptoms developing after ingestion of lactose which do not develop after placebo challenge in a person with lactose maldigestion. Such blinded testing might be especially important in those with functional gastrointestinal diseases in whom self-reported lactose intolerance is common. However, placebo-controlled testing is not part of current clinical practice. Updated protocols and high-quality outcome studies are needed. Treatment options of lactose intolerance include lactose-reduced diet and enzyme replacement. Documenting the response to multiple doses can guide rational dietary management; however, the clinical utility of this strategy has not been tested. This review summarizes the genetic basis, diagnosis, and treatment of lactose malabsorption and intolerance.

Keywords: Blinded testing; FODMAP; genetic test; hydrogen breath test; irritable bowel syndrome; lactase deficiency; lactose intolerance; lactose malabsorption; lactose maldigestion; multiple-dose testing.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Interpolated frequency of the lactose malabsorption phenotype in the Eastern Hemisphere Dots indicate locations of data collection. In regions with few data points (for instance Australia) this map is less reliable. Figure modified from Itan et al.
Figure 2.
Figure 2.
Diagnostic algorithm for diagnosing lactose malabsorption and lactose intolerance Diagnosis of lactose malabsorption is a pre-requisite for diagnosis of lactose intolerance (LI). Tests of malabsorption (genetic, biopsy) should be followed by a test of intolerance before lactose restriction is recommended. Blinded testing at multiple doses in the home setting may help guide rational dietary management; however, protocols still need to be established. LI, lactose intolerance; IBS, irritable bowel syndrome; SIBO, small intestinal bacterial overgrowth.

References

    1. Brannon PM, Carpenter TO, Fernandez JR, et al. NIH consensus development conference statement: lactose intolerance and health. NIH Consens State Sci Statements 2010; 27: 1–27. PMID: 20186234. - PubMed
    1. Gasbarrini A, Corazza GR, Gasbarrini G, et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther 2009; 29(Suppl 1): 1–49 - PubMed
    1. Ingram CJ, Mulcare CA, Itan Y, et al. Lactose digestion and the evolutionary genetics of lactase persistence. Hum Genet 2009; 124: 579–591 - PubMed
    1. Scrimshaw NS, Murray EB. The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance. Am J Clin Nutr 1988; 48: 1079–1159 - PubMed
    1. Itan Y, Jones BL, Ingram CJ, et al. A worldwide correlation of lactase persistence phenotype and genotypes. BMC Evol Biol 2010; 10: 36–36 - PMC - PubMed